Prostate Cancer - Results from #160

Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer. May 5, 2023

Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative? May 5, 2023

Bone Health in Prostate Cancer Survivors: Recent Lessons and Opportunities for Improvement. May 5, 2023

Genomic classifier performance in intermediate-risk prostate cancer: Results from NRG Oncology/RTOG 0126 randomized phase III trial. May 5, 2023

Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study. May 4, 2023

Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide. May 4, 2023

Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer. May 4, 2023

LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer. May 4, 2023

Ejaculation Frequency and Prostate Cancer: CAPLIFE Study. May 4, 2023

Application of machine learning algorithm in prediction of lymph node metastasis in patients with intermediate and high-risk prostate cancer. May 3, 2023

Impact of 18F-fluciclovine PET/CT on plans for androgen deprivation therapy in patients with biochemical recurrence of prostate cancer: data analysis from two prospective clinical trials. May 3, 2023

Combined ARFI and Shear Wave Imaging of Prostate Cancer: Optimizing Beam Sequences and Parameter Reconstruction Approaches. May 3, 2023

Intra-Practice Urologist-Level Variation in Targeted Fusion Biopsy Outcomes. May 3, 2023

Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers. May 3, 2023

YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. May 3, 2023

Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression. May 3, 2023

The Imperative for Population-based Cancer Registration of All Metastatic Cancers. May 2, 2023

Diagnostic Performance and Safety of 18F-rhPSMA-7.3 PET in Men with Suspected Prostate Cancer Recurrence: Results from a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). May 2, 2023

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. May 2, 2023

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. May 2, 2023

Page 9 of 1306